… HPV vaccine. In an effectiveness study covering the entire Swedish population, HPV vaccine
effectiveness against genital warts … <14 years) and vaccine effectiveness decreased with …

… HPV vaccine, the question now is whether the vaccine is in fact … Gardasil ® the question of
which clinical endpoint should be monitored, was addressed. Clearly the most significant HPV-…

… the vaccine was introduced, reductions in HPV vaccine type prevalence and genital warts
have … impact, but the initial studies show promising results for the relatively new HPV vaccine. …

… quadrivalent HPV vaccine were effective against genital warts in our population. Moreover,
with low vaccine coverage the incidence of genital warts decreased only in the vaccinated. …

… school-based HPV vaccination programme in boys … genital warts at a large Australian sexual
health centre 7 years after the implementation of the national quadrivalent HPV vaccination …

… In this study, we describe the ongoing population effect of the quadrivalent human
papillomavirus vaccination programme on genital warts in Australian patients five years after the …

… of the national HPV vaccination program on private in-patient treatments for genital warts. …
the impact of the HPV vaccine program on in-patient treatment of genital warts in Australia. We …

… genital warts cases attributable to HPV in Europe The estimated annual number of new genital
warts … low-risk 9-valent HPV vaccine types account for 90% of all genital warts cases [18], …

… . Rapid decline in presentations of genital warts after the implementation of a national
quadrivalent human papillomavirus vaccination programme for young women. Sex Transm Infect …

… -associated disease in vaccinated individuals. To derive the greatest public health benefit,
HPV vaccines offering protection from cervical cancer and genital warts will, ideally, be …